By Admin at 9 Dec 2015

One of the main hurdles to increasing outcomes among ovarian cancer patients is resistance to chemotherapy. It’s estimated that 75 percent of women with advanced ovarian cancer initially respond to chemotherapy treatment, but the majority will relapse within two years.